StonvexLoading…
StonvexStonvexStonvexCore line items from GBCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.29M | $41.44M | $31.77M | $20.93M |
Operating Income | $-1.26M | $-1.56M | $-1.17M | $-872.03K |
Net Income | $6.53M | $-1.02M | $-211.63K | $-964.00K |
EPS (Diluted) | $1.90 | $-0.34 | $-0.08 | $-0.32 |
Total Assets | $30.01M | $32.58M | $33.26M | $33.64M |
Total Liabilities | $29.75M | $38.79M | $38.92M | $40.03M |
Cash & Equivalents | $1.29M | $1.01M | $417.13K | $559.98K |
Free Cash Flow OCF − CapEx | $-2.67M | $1.44M | $851.07K | $575.28K |
Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M |